Skip to content
Home/Companies/Biotech/Ermium
ER

Ermium

Biotech·France·Active·7yr hold

Ermium is a healthcare / biotech company, headquartered in France.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns Ermium?

Ermium is currently owned by Eurazeo through Kurma Biofund III (2017 vintage), since 2019.

Hand-verified · updated 2026-04-21

Eurazeo
Investor
Eurazeo
Kurma Biofund III · 2017 · Healthcare

Key facts

HQFrance
SectorHealthcare / Biotech

More from Kurma Biofund III

Other portfolio companies in the same fund.

ImCheck
Exited 2025
BiotechFrance· 2020
to
Amolyt Pharma
Exited 2024
BiotechFrance· 2019
to
IO Biotech
Active
BiotechDenmark· 2019
Pharvaris
Active
BiotechNetherlands· 2019
Vivet
Active
BiotechFrance· 2019
Orphazyme
Active
BiotechDenmark· 2017

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings